Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Up 236.3% in December

Sharps Technology, Inc. (NASDAQ:STSS) was the target of a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 137,200 shares, an increase of 236.3% from the November 30th total of 40,800 shares. Based on an average daily trading volume, of 190,600 shares, the days-to-cover ratio is currently 0.7 days. Currently, 7.9% of the company’s stock are sold short.

Sharps Technology Trading Down 2.0 %

Shares of STSS traded down $0.04 during mid-day trading on Friday, reaching $1.97. 32,759 shares of the stock traded hands, compared to its average volume of 203,569. The stock has a market cap of $3.54 million, a price-to-earnings ratio of -0.24 and a beta of 1.37. The firm has a fifty day moving average of $2.66. Sharps Technology has a 12-month low of $1.70 and a 12-month high of $18.15.

Institutional Investors Weigh In On Sharps Technology

An institutional investor recently bought a new position in Sharps Technology stock. Garden State Investment Advisory Services LLC bought a new position in shares of Sharps Technology, Inc. (NASDAQ:STSS) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 172,909 shares of the company’s stock, valued at approximately $26,000. Garden State Investment Advisory Services LLC owned about 9.61% of Sharps Technology as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 17.17% of the company’s stock.

Sharps Technology Company Profile

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.